ProKyma Gets $783K for CTC Detection Technology Development | GenomeWeb

NEW YORK (GenomeWeb News) – UK firm ProKyma today announced a £482,000 ($783,211) grant from the National Institute for Health Research to further develop its technology to detect circulating tumor cells.

The funding will be used by the spinout of the Defence Science and Technology Laboratory — a center of scientific excellence for the Ministry of Defence — to use its KymaSep technology to find a patient's specific cancer mutation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.